Ethicon Transvaginal Mesh Complications Result in $13.5M Verdict at Trial in Philadelphia

|

A Philadelphia jury has awarded $13.5 million in damages to a woman who suffered severe and debilitating complications after an Ethicon transvaginal mesh product moved out of position.ย 

The verdict was handed down in the Philadelphia Court of Common Pleas on Wednesday, marking the second state court vaginal mesh lawsuit over the past three months to result in a multi-million dollar damage award against Johnson & Johnson’s Ethicon subsidiary.

The manufacturer faces nearly 50,000 similar claims brought by women throughout the United States, each involving allegations that the mesh used for repair of pelvic organ prolapse or female stress urinary incontinence migrated through the vagina, caused infections and other painful injuries.

|
|

Following a two week trial involving a case filed by Sharon Carlino, the jury awarded $3.5 million in compensatory damages and hit the Johnson & Johnson subsidiary with an additional $10 million in punitive damages, which is designed to punish the medical device manufacturer for their actions involving the manufacture and sale of the mesh product.

In December, another Philadelphia jury awarded $12.5 million in damages in a case filed by Patricia Hammons, including $7 million in punitive damages.

While there have been some recent reports suggesting that Ethicon is attempting to settle some vaginal mesh cases, additional trials are expected over the coming year if the manufacturer fails to resolve the litigation.

Other manufacturers of similar products have agreed to pay hundreds of millions in vaginal mesh settlements to resolve claims, and Bloomberg News reports that Johnson & Johnson has set aside more than $1 billion to deal with the claims.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

An Abbott spinal cord stimulator lawsuit filed by three women says the product was defectively designed, inappropriately approved by the FDA, and left them with severe injuries, worsening pain and the need for removal surgery.
A Georgia couple’s lawsuit claims the makers of Dupixent failed to provide adequate warnings about the risk of mycosis fungoides, a type of T-cell lymphoma.
In a joint statement, plaintiffs and defendants in AngioDynamics port catheter lawsuits have laid guidelines for what types of cases should be selected to serve as potential bellwether trials.